What did the $4 million accomplish?
Thanks to the $4 million raised through the Ice Bucket Challenge we were able to make significant
strides in our work to find treatments for ALS. Here's what we invested in:
Precision Medicine Program
$2 million was invested in our Precision Medicine Program
, allowing us to rapidly expand the program from 25 to
300 participants. The program now has 632 people enrolled.
Anti-CD40L Antibody Development
$2 million was invested into anti-CD40L antibody development
Now called AT-1501, it entered a phase 1 clinical trial in November of 2018, making ALS TDI the first nonprofit biotech in any disease to develop a potential treatment
and bring it from our own lab, through FDA review and into clinical trial.